DK677688A - Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne - Google Patents

Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne

Info

Publication number
DK677688A
DK677688A DK677688A DK677688A DK677688A DK 677688 A DK677688 A DK 677688A DK 677688 A DK677688 A DK 677688A DK 677688 A DK677688 A DK 677688A DK 677688 A DK677688 A DK 677688A
Authority
DK
Denmark
Prior art keywords
human
somatometricated
procedures
manufacturing
protein substances
Prior art date
Application number
DK677688A
Other languages
English (en)
Other versions
DK677688D0 (da
Inventor
Emerald Martin Spencer
Original Assignee
Biogrowth Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogrowth Inc filed Critical Biogrowth Inc
Publication of DK677688A publication Critical patent/DK677688A/da
Publication of DK677688D0 publication Critical patent/DK677688D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK677688A 1987-04-06 1988-12-05 Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne DK677688D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3488587A 1987-04-06 1987-04-06
PCT/US1988/001042 WO1988007863A1 (en) 1987-04-06 1988-03-31 Human somatomedin carrier protein subunits and process for producing them

Publications (2)

Publication Number Publication Date
DK677688A true DK677688A (da) 1988-12-05
DK677688D0 DK677688D0 (da) 1988-12-05

Family

ID=21879212

Family Applications (1)

Application Number Title Priority Date Filing Date
DK677688A DK677688D0 (da) 1987-04-06 1988-12-05 Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne

Country Status (11)

Country Link
EP (2) EP0308500B1 (da)
JP (1) JP2648951B2 (da)
AT (1) ATE90690T1 (da)
AU (1) AU627423B2 (da)
CA (1) CA1340295C (da)
DE (1) DE3881801T2 (da)
DK (1) DK677688D0 (da)
ES (1) ES2058341T3 (da)
IL (1) IL85983A (da)
WO (1) WO1988007863A1 (da)
ZA (1) ZA882407B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973115A (en) * 1987-05-15 1999-10-26 Amgen Inc. Method for potentiating and inhibiting insulin-like growth factor activity
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
ATE132164T1 (de) * 1988-04-12 1996-01-15 Amgen Boulder Inc Verfahren zur steigerung und zur hemmung der wirkung eines insulinähnlichen wachstumfaktors
US6465423B1 (en) 1988-07-15 2002-10-15 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
CA1341598C (en) * 1988-07-15 2009-09-29 Central Sydney Area Health Service Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex
US5324820A (en) * 1988-07-15 1994-06-28 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
RU2126683C1 (ru) * 1992-12-17 1999-02-27 Товарищество с ограниченной ответственностью "САМИ" Способ получения антисоматотропной сыворотки
CA2195474A1 (en) * 1994-07-20 1996-02-01 Cedo Martin Bagi Igf/igfbp complex for promoting bone formation and for regulating bone remodeling
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
JP2002535967A (ja) 1999-01-06 2002-10-29 ジェネンテック・インコーポレーテッド インシュリン様成長因子（ｉｇｆ）ｉ変異体
AU762351B2 (en) 1999-01-06 2003-06-26 Genentech Inc. Insulin-like growth factor (IGF) I mutant variants
ATE389416T1 (de) 2000-05-16 2008-04-15 Genentech Inc Behandlung von knorpelerkrankungen
WO2002072780A2 (en) 2001-03-14 2002-09-19 Genentech, Inc. Igf antagonist peptides
CA2524305C (en) 2003-05-01 2015-12-08 Imclone Systems Incorporated Fully human antibodies directed against the human insulin-like growth factor-1 receptor
EP2274978B1 (en) 2003-09-12 2015-05-20 Tercica, Inc. Methods for treatment of insulin-like growth factor-I(IGF-I) deficiency
US7192738B2 (en) 2003-10-03 2007-03-20 Genentech, Inc. IGF binding proteins
CA2612449A1 (en) 2005-06-17 2006-12-28 Imclone Systems Incorporated Receptor antagonists for treatment of metastatic bone cancer
AP2008004569A0 (en) 2006-02-03 2008-08-31 Imclone Systems Inc IGR-IR antagonists as adjuvants for treatment of prostrate cancer
CA3075482A1 (en) 2017-09-11 2019-03-14 Shire Human Genetic Therapies, Inc. Methods and compositions for treating chronic lung diseases
MX2023004426A (es) 2020-10-19 2023-08-04 Oak Hill Bio Ltd Composiciones adecuadas para su uso en neonatos.
AU2023210427A1 (en) 2022-01-19 2024-08-22 Oak Hill Bio Limited Compositions and methods for reducing oxidation of igf‐1/igfbp
WO2023242440A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Treament of lungs in infants
WO2023242442A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Method of maturing/differentiating neurons and/or modulating the vagus nerve
WO2023242439A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Vascular stabilisation (preterm infants)
CN120882420A (zh) 2023-02-14 2025-10-31 奥克希尔生物有限公司 Gi组织中愈合失调的治疗

Also Published As

Publication number Publication date
EP0308500A1 (en) 1989-03-29
AU627423B2 (en) 1992-08-27
ES2058341T3 (es) 1994-11-01
DE3881801T2 (de) 1993-12-23
IL85983A0 (en) 1988-09-30
DE3881801D1 (de) 1993-07-22
EP0308500B1 (en) 1993-06-16
CA1340295C (en) 1998-12-29
DK677688D0 (da) 1988-12-05
IL85983A (en) 1994-10-07
JPH01502986A (ja) 1989-10-12
ZA882407B (en) 1988-09-28
JP2648951B2 (ja) 1997-09-03
EP0294021A1 (en) 1988-12-07
ATE90690T1 (de) 1993-07-15
AU1702088A (en) 1988-11-04
WO1988007863A1 (en) 1988-10-20

Similar Documents

Publication Publication Date Title
DK677688A (da) Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne
DK95291A (da) Rekombinante dna-molekyler
DK564989A (da) Bindingsproteiner
US5043429B1 (en) Protein fragments containing factor VIII binding domain of von willebrand factor
WO1994004691A3 (en) Dimer and multimer forms of single chain polypeptides
NZ224057A (en) A polypeptide of a vascular anticoagulant protein and method of preparation
DK0458841T3 (da) Fremgangsmåde til anvendelse og fremstilling af peptider
DK643087D0 (da) Fremgangsmaade til isomerisering af en kulbrintefoedestroem
DE69000338D1 (de) Expressionssystem zur herstellung von chimaeren monoklonalen antikoerpern.
FI97299C (fi) Menetelmä kimeerisen transformoivan beta-kasvutekijän valmistamiseksi
FI953525L (fi) Kemiallinen syntetointimenetelmä fibronektiiniä sitovan proteiinin tai polypeptidin valmistamiseksi
ATE186781T1 (de) Verfahren zur herstellung von testelementen
NO930428D0 (no) Proteinstrukturen til plantetoksingelonin
HUT55800A (en) Process for producing anticoagulant peptides
DE3461093D1 (en) Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mrnas, receptors, methods and diagnostics using the same
HU896448D0 (en) Process for the preparation of anticoagulant peptides
DE3881101D1 (de) Monoklonal-antikoerper und methode fuer die bereitung von hybridoma, produzierend diese antikoerper.
DK142147B (da) Fremgangsmaade til rensning af serumproteinkonjugater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment